5/17/2024  9:59:57 PM Chg. +1.86 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
144.31USD +1.30% 50,033
Turnover: 7.18 mill.
-Bid Size: - -Ask Size: - 23.38 bill.USD 1.97% 19.02

Business description

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States.
 

Management board & Supervisory board

CEO
James E. Davis
Management board
Sam Samad, Catherine T. Doherty, Cecilia McKenney, Dermot Shorten, Gabrielle Wolfson, Gary D. Samuels, Michael E. Prevoznik, Richard Adams, Mark Delaney, Mark Gardner, Karthik Kuppusamy, Patrick Plewman, Kristin Wallace
Supervisory board
James E. Davis, Denise M. Morrison, Dr. Gail R. Wilensky, Gary M. Pfeiffer, Timothy L. Main, Timothy M. Ring, Tracey C. Doi, Vicky B. Gregg, Wright L. Lassiter, III, Luis A. Diaz, Jr.
 

Company data

Name: Quest Diagnostics Inc.
Address: 500 Plaza Drive,Secaucus, NJ 07094, USA
Phone: +1-973-520-2700
Fax: -
E-mail: -
Internet: www.questdiagnostics.com
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 12/31
Free Float: 74.48%
IPO date: 12/31/1996

Investor relations

Name: Shawn Bevec
IR phone: +1-973-520-2900
IR Fax: -
IR e-mail: Investor@questdiagnostics.com